Major pharmaceutical companies are racing to launch breakthrough drugs to treat advanced melanoma, the deadliest form of skin cancer.
These majors include:
Bristol-Myers Squibb
Roche Holding
Merck
AstraZeneca
I wonder which of these four will be the first in making a call to Cellmid & Co.
The mind boggles when looking at the $'s on offer for a ground breaking new drugs.
The above four are no different to other any other food, engineering or manufacturing businesses; they need new innovative products to grow revenue streams and be a market leader
Well, Midkine can possibly provide that opportunity.
CDY Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held